Search

Search results

76 results found

Toward the use of surgical placebo-controlled trials. Transplantation Proceedings1997;29:1925.

Publication: Journal Article

Freeman, TB, D Vawter, CG Goetz, PE Leaverton, RA Hauser, PR Sanberg, JH Godbold, and CW Olanow. 1997. “Toward the Use of Surgical Placebo-Controlled Trials. Transplantation Proceedings1997;29:1925.”. Transplantation Proceedings.

Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Canadian Journal of Neurological Sciences 1996;23:95-98.

Publication: Journal Article

Hauser, RA, TA Zesiewicz, C Martinez, AS Rosemurgy, and CW Olanow. 1996. “Blood Manganese Correlates With Brain Magnetic Resonance Imaging Changes in Patients With Liver Disease. Canadian Journal of Neurological Sciences 1996;23:95-98.”. Canadian Journal of Neurological Sciences.

Ropinirole in the treatment of Parkinson’s disease. Expert Opinion on Investigational Drugs 1999;8:697-710.

Publication: Journal Article

Zesiewicz, TA, and RA Hauser. 1999. “Ropinirole in the Treatment of Parkinson’s Disease. Expert Opinion on Investigational Drugs 1999;8:697-710.”. Expert Opinion on Investigational Drugs.

Depression and Anxiety in Parkinson’s Disease. American Journal of Geriatric Psychiatry. 1999;7:110-118.

Publication: Journal Article

Zesiewicz, TA, M Gold, G Chari, and RA Hauser. 1999. “Depression and Anxiety in Parkinson’s Disease. American Journal of Geriatric Psychiatry. 1999;7:110-118.”. Am J Geriatr Psych.

Clinical trials of add-on medications in Parkinson’s disease: efficacy versus usefulness. Parkinsonism & Related Disorders 1997;3:1-6.

Publication: Journal Article

Hauser, RA, TA Zesiewicz, SA Factor, M Guttman, and WJ Weiner. 1997. “Clinical Trials of Add-on Medications in Parkinson’s Disease: Efficacy versus Usefulness. Parkinsonism & Related Disorders 1997;3:1-6.”. Parkinsonism and Related Disorders.

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease. Neurology 2001;56:455-462.

Publication: Journal Article

Group, Parkinson Study. 2001. “A Randomized, Controlled Trial of Remacemide For Motor Fluctuations in Parkinson’s Disease. Neurology 2001;56:455-462.”. Neurology.

Dr. Andrea Contreras Marciales presents at 6th International Symposium on Pathomechanisms of Amyloid Diseases

News: December 05, 2024

Dr. Contreras Marciales gives Flash Talk and Poster Presentation The 6 th International Symposium on Pathomechanisms of Amyloid Diseases took place on December 4-6, 2024 in Tallahassee, Florida. Dr. Andrea Contreras Marciales presented a Flash Talk and Poster Presentation on her recent work studying...

Dr. Blair presents at the Neurodysfunction and Neurodegeneration Seminar Series

News: December 10, 2024

Dr. Laura Blair give seminar on lab's efforts to control tau through molecular chaperones Dr. Blair presented on "Chaperone Control of Tau: A Double-Edged Sword” at the virtual Neurodysfunction and Neurodegeneration Seminar Series, which is a joint seminar series for University of Texas Medical...

Initial experience with electroconvulsive therapy for progressive supranuclear palsy. Movement Disorders 1994;9:467-469.

Publication: Journal Article

Hauser, RA, and R Trehan. 1994. “Initial Experience With Electroconvulsive Therapy for Progressive Supranuclear Palsy. Movement Disorders 1994;9:467-469.”. Movement Disorders.

The effect of L-dopa infusions with and without phenylalanine challenges in parkinsonian patients: plasma and ventricular CSF L-dopa levels and clinical responses. Neurology 1993;43:1704-1708.

Publication: Journal Article

Woodward, WR, CW Olanow, RM Beckner, RA Hauser, LL Gauger, JM Cedarbaum, and J Nutt. 1993. “The Effect of L-Dopa Infusions With and Without Phenylalanine Challenges in Parkinsonian Patients: Plasma and Ventricular CSF L-Dopa Levels and Clinical Responses. Neurology 1993;43:1704-1708.”. Neurology.